Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dose rate dependence of incorrect sensing and triggering of defibrillation in cardiac implantable electronic devices: single manufacturer result with kV beam.

Radiological physics and technology·2026

Same author

Acute Calcium Pyrophosphate Crystal Arthritis Occurring Many Years After Total Knee Arthroplasty: A Case Report.

Cureus·2026

Same author

Impact of neutron sieve therapy for deep site in boron neutron capture therapy using Monte Carlo calculation.

Radiation protection dosimetry·2026

Same author

Congenital Complex Fusion Fistula Connecting the Internal Mammary Artery, Pulmonary Vein, and Coronary Artery-Pulmonary Artery Fistula.

JACC. Case reports·2025

Same author

Eight-Year Outcomes of Cardiosphere-Derived Cells in Single Ventricle Congenital Heart Disease.

Journal of the American Heart Association·2024

Same author

Cardiac Rehabilitation for Patients With Stable Ischemic Heart Disease Without Revascularization　- Rationale and Design of a Single-Arm Pilot Study.

Circulation reports·2023

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Stemming heart failure with cardiac- or reprogrammed-stem cells.

Kento Tateishi¹, Naofumi Takehara, Hiroaki Matsubara

¹Department of Experimental Therapeutics, Translational Research Center, Kyoto University Hospital, and Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Journal of Cellular and Molecular Medicine

|August 30, 2008

Summary

This summary is machine-generated.

Adult cardiomyocytes divide infrequently, limiting natural heart repair. Cardiac stem cells (CSCs) show potential but need enhancement for effective myocardial regeneration. Induced pluripotent stem cells offer a promising alternative source for patient-specific CSCs.

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

Related Experiment Videos

Last Updated: Jul 2, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

Area of Science:

Cardiovascular Biology
Regenerative Medicine
Stem Cell Biology

Background:

Adult cardiomyocytes exhibit limited proliferative capacity, hindering natural cardiac repair following stress or injury.
While tissue-resident stem cells are known in many organs, their role in adult mammalian heart regeneration remains insufficient for full functional recovery.
Cardiac stem cells (CSCs) are present in the adult heart but possess limitations in proliferation and differentiation for effective cardiomyocyte replenishment.

Purpose of the Study:

To explore the potential of cardiac stem cells (CSCs) for myocardial regeneration.
To identify strategies for enhancing CSC survival, proliferation, and differentiation for therapeutic applications.
To investigate induced pluripotent stem (iPS) cells as an alternative source for patient-specific CSC generation.

Main Methods:

Review of current literature on cardiomyocyte proliferation, cardiac stem cells, and induced pluripotent stem cells.
Analysis of challenges and strategies for ex vivo CSC expansion and transplantation.
Examination of fibroblast reprogramming into iPS cells for potential cardiac regenerative therapies.

Main Results:

Adult cardiomyocytes have a restricted ability to divide and replace damaged tissue.
Cardiac stem cells (CSCs) show therapeutic potential but require optimized conditions for in vivo efficacy.
Induced pluripotent stem (iPS) cells derived from fibroblasts can differentiate into cardiomyocytes, offering a patient-specific cell source.

Conclusions:

Effective cardiac repair necessitates strategies beyond the limited regenerative capacity of adult cardiomyocytes.
Ex vivo expanded cardiac stem cells (CSCs) require integrated approaches involving growth factors and tissue engineering for successful transplantation.
Induced pluripotent stem (iPS) cell technology presents a viable alternative for generating patient-specific cells for cardiac regenerative medicine.